CLEVELAND, Sept. 5 /PRNewswire-FirstCall/ -- DATATRAK International,
Inc. (Nasdaq: DATA), a technology company focused on global eClinical
solutions for the clinical trials industry, today reported that it will be
presenting at the Roth Capital Partners 2006 New York City Conference on
Thursday, September 7, 2006 at 1:00 P.M. at the Westin New York Hotel at
Times Square. The live presentation, together with the accompanying slides,
will be available via live web cast on the DATATRAK International, Inc. web
site by clicking the button labeled "Click here for Live Web Cast, DATATRAK
Presents at Roth Capital Partners 2006" on the Company's homepage at
http://www.datatrak.net a few minutes before 1:00 P.M. ET.
DATATRAK International, Inc. is a worldwide technology company focused
on the provision of multi-component eClinical solutions and related
services for the clinical trials industry. The Company delivers a complete
portfolio of software products that were created in order to accelerate
clinical research data from investigative sites to clinical trial sponsors
and ultimately the FDA, faster and more efficiently than manual methods or
loosely integrated technologies. DATATRAK's eClinical software suite can be
deployed worldwide through an ASP offering or in a licensed Technology
Transfer model that fully empowers its clients. The DATATRAK software suite
and its earlier versions have successfully supported hundreds of
international clinical trials involving thousands of clinical research
sites and encompassing tens of thousands of patients in 56 countries.
DATATRAK International, Inc.'s product suite has been utilized in some
aspect of the clinical development of 16 separate drugs that have received
regulatory approval from either the United States Food and Drug
Administration or counterpart European bodies. DATATRAK International, Inc.
has offices located in Cleveland, Ohio, Bonn, Germany, and Bryan, Texas.
Its common stock is listed on the NASDAQ stock Market under the ticker
symbol "DATA". Visit the DATATRAK International, Inc. web site at
http://www.datatrak.net.
Except for the historical information contained in this press release,
the statements made in this release are forward-looking statements. Factors
that may cause actual results to differ materially from those in the
forward- looking statements include the ability of the Company to absorb
corporate overhead and other fixed costs in order to successfully market
its software; the development and fluctuations in the market for clinical
trial technology; the degree of the Company's success in obtaining new
contracts; the timing of payments from customers and the timing of clinical
trial sponsor decisions to conduct new clinical trials or cancel or delay
ongoing trials; governmental regulation; the early stage of the Company's
business and operations; and general economic conditions. In addition, the
Company's success depends on the outcome of various strategic initiatives
it has undertaken, all of which are based on assumptions made by the
Company concerning trends in the clinical research market and the health
care industry.
SOURCE DATATRAK International, Inc.
 back to top
Related links:
http://www.datatrak.net
CONTACT:
Jeffrey A. Green, Pharm.D., FCP, President
and Chief Executive Officer, x112, or Terry C. Black, Chief
Financial Officer, x110, both of DATATRAK International, Inc.,
+1-440-443-0082; or Neal Feagans, Investor Relations of Feagans
Consulting, Inc., +1-303-449-1184
|
